PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#transdermal patch ×

UPDATED
Regulatorische Updates
10. Sept. 2026•1 Min. Lesezeit
FDA Approves TRANSDERM SCOP (NDA017874) Transdermal Scopolamine Patch
The FDA has approved the prescription transdermal patch TRANSDERM SCOP, containing 1 mg scopolamine per 72 hr, under NDA 017874. Baxter Healthcare is the manufacturer.
UPDATED
Regulatorische Updates
3. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA210272 for Buprenorphine Transdermal Patch
The FDA has approved application ANDA210272 for a buprenorphine transdermal patch, covering five dosage strengths and requiring a REMS program.